Acute-On-Chronic Liver Failure
83
15
16
16
Key Insights
Highlights
Success Rate
84% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
3.6%
3 terminated out of 83 trials
84.2%
-2.3% vs benchmark
8%
7 trials in Phase 3/4
0%
0 of 16 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 16 completed trials
Clinical Trials (83)
COOLEY- Study: aCute On chrOnic Liver failurE Using the cYtosorb Device
Efficacy and Safety of Cytokine Adsorption and Plasma Exchange in Patients With ACLF and Sepsis
Pharmacokinetic Study on G1090N (Nitazoxanide) Capsules in Healthy Volunteers
Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)®
The Effects of Double Plasma Molecular Adsorption System in Acute on Chronic Liver Failure Patients
Short-term Survival of Subjects With Acute-on-chronic Liver Failure After Plasma Exchange With Human Serum Albumin 5%
Risk Factors Affecting MSC Efficacy in ACLF Patients
F573 for Injection for the Treatment of Liver Injury/Failure
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Phase I Study on Safety and Efficacy of Mesenchymal Stem-Cell (MSC) Therapy in Non-Viral Acute-on-Chronic Liver Failure (ACLF)
National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem Cell Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patient- Phase-II Trial
National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem-Cell (MSC) Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patients - Phase-III Trial
A-TANGO Phase 2 Study
Comparison of Blood Products Required Using Two Different ROTEM Cut-offs Before Invasive Procedures in Cirrhosis and Acute on Chronic Liver Failure (ACLF) Patients With Severe Coagulopathy
Micro-encapsulated Hepatocyte Intraperitoneal Transplantation in Liver Failure Adults
Intravenous BCAA for HE in ACLF (BCAA-HE-ACLF)
Anti-fungal Strategies in Acute-on-Chronic Liver Failure Patients
Phase I Trial of QH-1A Hybrid Bio-Artificial Liver With Ex Vivo Blood-Purifying MSCs in Acute-on-Chronic Liver Failure
Chinese Phase II Trail of AS1501 in Acute-on-chronic Liver Failure (ACLF) Patients
Umbilical Cord-derived Mesenchymal Stem Cell Infusion for Treating ACLF